New England Securities’s AstraZeneca AZN Stock Holding History

New England Securities’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$14K	Buy	+200	New	+$14.3K	﹤0.01%	984
2014 Q1	–	Sell	-2,152	Closed	-$128K	–	1721
2013 Q4	$128K	Sell	2,152 -230	-10%	-$12.5K	0.05%	359
2013 Q3	$124K	Buy	2,382 +34	+1%	+$1.71K	0.06%	309
2013 Q2	$111K	Buy	+2,348	New	+$120K	0.07%	277

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

New England Securities's AZN Position: Q4 2014 in Review

New England Securities opened a new position in AstraZeneca (AZN) in Q4 2014: 200 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #984 among its holdings. This is a return to the name: New England Securities previously reported a position in AZN as recently as Q4 2013.

New England Securities first reported a position in AZN in Q2 2013 and has held it in 4 quarters since. The position peaked at $128K in Q4 2013. 404 funds tracked by Wall St. Rank hold AZN as of Q4 2014.

New England Securities held 200 shares of AstraZeneca worth $14K as of Q4 2014.
AstraZeneca was a new New England Securities position in Q4 2014.
AstraZeneca made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #984 holding.
New England Securities first reported a position in AstraZeneca in Q2 2013 and has held it in 4 quarters since.
New England Securities's AstraZeneca position peaked at $128K in Q4 2013.
404 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.